ADIPOTIDE
Tried ADIPOTIDE? Be part of the collective knowledge. Share your experience - your insights help others on their journey.
What Is ADIPOTIDE?
Adipotide is a peptidomimetic compound designed to induce targeted apoptosis in the blood vessels of white adipose tissue by binding to specific receptors in the fat-cell vasculature. By cutting off the blood supply to fat cells, it causes them to die and be resorbed, leading to rapid reductions in body weight and improved insulin sensitivity.
ADIPOTIDE Research & Studies
01 A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys ▸
This study demonstrated that Adipotide treatment in obese monkeys led to significant weight loss, reduction in white fat volume via MRI, and improved insulin resistance.
View Study (PubMed)02 Peptide designed to elicit apoptosis in adipose tissue endothelium reduces food intake and body weight ▸
Research in rodents showed that targeting the adipose vasculature not only reduces fat mass but also suppresses appetite and alters the neuroendocrine system to favor lower body weight.
View Study (PubMed)03 Rapid and Weight-Independent Improvement of Glucose Tolerance Induced by a Peptide Designed to Elicit Apoptosis in Adipose Tissue Endothelium ▸
Findings indicate that Adipotide provides metabolic benefits and improves glucose tolerance very rapidly, sometimes even before significant weight loss occurs.
View Study (PubMed)04 Reversal of obesity by targeted ablation of adipose tissue ▸
The foundational study using phage display to identify the CKGGRAKDC peptide sequence, proving that targeted destruction of fat-supporting blood vessels reverses obesity in mice.
View Study (PubMed)ADIPOTIDE User Reviews & Experiences
*Based on large scale analysis of publicly available user experiences
Users are polarized; while the fat loss is described as uniquely rapid and visible, the high incidence of kidney-related side effects and the experimental nature of the compound create significant hesitation.
ADIPOTIDE Benefits, Dosage & Side Effects
- Targeted Fat Loss: Users report specific reduction in stubborn white adipose tissue, often seeing changes in areas resistant to diet.
- Appetite Suppression: Similar to GLP-1 agonists, users note a marked decrease in hunger and daily caloric intake.
- Metabolic Shift: Research indicates a rapid improvement in glucose processing and insulin sensitivity.
- Speed of Results: Adipotide is noted for working faster than traditional peptides, with measurable changes often occurring within initial weeks.
- Primate Translation: Unlike many fat burners, Adipotide's effectiveness was specifically proven in non-human primates, increasing user confidence in its biological potency.
- Weight Independence: Metabolic improvements often manifest even before significant scale weight is lost.
- Experimental Range: Common user discussions mention ranges of 4.3 mg/kg based on primate studies, though human enthusiasts often use much lower 'micro-doses' to mitigate risk.
- Cycle Length: Usually taken in short cycles (e.g., 28 days) followed by long breaks to monitor kidney health.
- Subcutaneous Injection: Administered via daily subcutaneous injections to maintain steady plasma levels.
- Renal Toxicity: The most significant concern is proximal tubule dysfunction, often manifesting as changes in hydration and kidney markers.
- Increased Thirst: Users frequently report extreme polydipsia (excessive thirst) and the need for high fluid intake.
- Lethargy: Some users experience significant fatigue during the treatment cycle as the body processes the apoptotic cell debris.
- Research Chemical Status: Strictly sold as a research chemical and not approved by the FDA for human consumption.
- Sourcing Risk: Due to its complexity, users warn of high-priced but low-purity 'fake' batches from unreliable vendors.
Related Compounds
Community Reviews
Share your experience with ADIPOTIDE and help others make informed decisions.
Write a Review
Sign in to leave a review